An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
D000230:Adenocarcinoma / Q000276:immunology; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002296:Carcinosarcoma / Q000276:immunology; D003536:Cystadenocarcinoma / Q000276:immunology*; D003537:Cystadenoma / Q000276:immunology; D000939:Epitopes; D005260:Female; D005833:Genital Neoplasms, Female / Q000276:immunology*; D006106:Granulosa Cell Tumor / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D066298:In Vitro Techniques; D010048:Ovarian Cysts / Q000276:immunology; D010051:Ovarian Neoplasms / Q000276:immunology*; D011233:Precipitin Tests; D011817:Rabbits / Q000276:immunology; D013724:Teratoma / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
D000951:Antigens, Neoplasm; D000939:Epitopes; D007106:Immune Sera